A government health panel has greenlit pricing for 52 essential medications aimed at improving public healthcare accessibility. Health Minister Mustafa Kamal confirmed the decision requires final cabinet endorsement before implementation. This regulatory move targets affordability and availability of critical life-saving drugs across the healthcare system, potentially impacting treatment costs for patients nationwide and strengthening the pharmaceutical sector's pricing framework.

Summary auto-generated by AI from the original publisher's content. Editorial standards.